---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-171517"
form_type: "8-K"
ticker: "IMA"
cik: "0001835579"
company_name: "ImageneBio, Inc."
filed_at: "2022-06-10T23:59:59+00:00"
generated_at: "2026-06-25T02:54:26.465310+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Ikena Oncology shareholders elect three Class I directors and ratify EY as auditor

## Summary
- Elected Iain D. Dukes (23.9M for), Maria Koehler (24.6M for), Otello Stampacchia (23.3M for) to 3-year terms.
- Ratified Ernst & Young as independent auditor for FY 2022 with 28.5M votes for, 1,095 against.
- Meeting held June 9, 2022; all stockholder proposals passed.

## SEC filing metadata
- accession: 0001193125-22-171517
- form_type: 8-K
- ticker: IMA
- cik: 0001835579
- company_name: ImageneBio, Inc.
- filed_at: 2022-06-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835579/000119312522171517/0001193125-22-171517-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835579/000119312522171517/d322633d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-171517
- JSON: https://secwatch.observer/filing/0001193125-22-171517.json
- Plain text: https://secwatch.observer/filing/0001193125-22-171517.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.